Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
or

Gbs Inc (GBS)

Gbs Inc (GBS)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.4732 -0.0002 (-0.04%) 10/26/22 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 0.4732 unch (unch) -
Quote Overview for Wed, Oct 26th, 2022
Day Low
0.4507
Day High
0.4854
Open 0.4800
Previous Close 0.4734 0.4734
Volume 11,000 11,000
Avg Vol 72,510 72,510
Stochastic %K 25.81% 25.81%
Weighted Alpha -73.82 -73.82
5-Day Change +0.0093 (+2.00%) +0.0093 (+2.00%)
52-Week Range 0.3600 - 2.8900 0.3600 - 2.8900
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 7,046
  • Shares Outstanding, K 14,890
  • Annual Sales, $ 440 K
  • Annual Income, $ -8,310 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 1.32
  • Price/Sales 16.13
  • Price/Cash Flow N/A
  • Price/Book 1.08
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.56
  • Most Recent Earnings $-0.14 on 08/31/22
  • Next Earnings Date N/A
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical Services

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.3800 +24.53%
on 09/28/22
Period Open: 0.4283
0.7100 -33.35%
on 10/04/22
+0.0449 (+10.48%)
since 09/26/22
3-Month
0.3600 +31.44%
on 09/23/22
Period Open: 0.6805
0.7868 -39.86%
on 08/05/22
-0.2073 (-30.46%)
since 07/26/22
52-Week
0.3600 +31.44%
on 09/23/22
Period Open: 2.1300
2.8900 -83.63%
on 11/30/21
-1.6568 (-77.78%)
since 10/26/21

Most Recent Stories

More News
GBS Inc. Announces Key Milestone in Prospective Study Comparing Glucose in Oral Fluids and Blood

The trial is single center, prospective study collecting coincident samples of oral fluids and blood to evaluate the time-course of glucose NEW YORK,...

GBS : 0.4732 (-0.04%)
GBS Inc. to Initiate Manufacturing on the University of Newcastle Australia Campus

NEW YORK, June 23, 2022 (GLOBE NEWSWIRE) -- GBS Inc. (Nasdaq: GBS), a life sciences company developing non-invasive, real-time diagnostic testing for...

GBS : 0.4732 (-0.04%)
GBS INC. Announces Adjournment of 2022 Annual Meeting of Stockholders to July 13, 2022

NEW YORK, June 16, 2022 (GLOBE NEWSWIRE) -- GBS Inc. (Nasdaq: GBS), a life sciences company developing non-invasive, real-time diagnostic testing for...

GBS : 0.4732 (-0.04%)
GBS Inc. Enters into Exclusivity Agreement for an Acquisition of Unique Point of Care Diagnostic Screening Technology Focused on Opioids and Drugs of Abuse

- Intelligent Fingerprinting Limited’s commercial-stage, revenue-generating platform technology would provide an expanded product upon which to leverage...

GBS : 0.4732 (-0.04%)
GBS Inc. to Present at the H.C. Wainwright Global Investment Conference

NEW YORK, May 16, 2022 (GLOBE NEWSWIRE) -- GBS Inc. (Nasdaq: GBS), a life sciences company developing non-invasive, real-time diagnostic testing for...

GBS : 0.4732 (-0.04%)
GBS Inc. to Hold Virtual 2022 Annual Shareholder Meeting on Thursday, June 16, 2022, at 4:00pm ET

NEW YORK, May 13, 2022 (GLOBE NEWSWIRE) -- GBS Inc. (Nasdaq: GBS), a life sciences company developing non-invasive, real-time diagnostic testing for...

GBS : 0.4732 (-0.04%)
GBS Inc. Reports Third Quarter 2022 Financial Results and Recent Business Highlights

- Initiated prospective study to collect coincident samples of oral fluid and blood following IRB approval - - Finalizing site selection at the University...

GBS : 0.4732 (-0.04%)
GBS Inc. to Present Third Quarter 2022 Financial Results and Recent Corporate Update on May 10

Company to Host Conference Call & Webcast at 4:30 p.m. ET...

GBS : 0.4732 (-0.04%)
GBS Inc. Announces Institutional Review Board Approval to Initiate Clinical Trial at Sutter Health Mills-Peninsula Medical Center

The trial is single center, prospective study to collect coincident samples of oral fluid and blood to evaluate the time-course of glucose Trial is...

GBS : 0.4732 (-0.04%)
GBS Inc. Reports Second Quarter 2022 Financial Results and Recent Business Highlights

- Discussions underway between the University of Newcastle and GBS to oversee the high-tech manufacturing facility supported by its $4.7 Million Grant...

GBS : 0.4732 (-0.04%)

Business Summary

GBS Inc. is a life sciences company. It engages in developing non-invasive, real-time diagnostic testing in the hands of patients and their primary health practitioners at point of care. GBS Inc. is based in NEW YORK.

See More

Key Turning Points

3rd Resistance Point 0.5235
2nd Resistance Point 0.5045
1st Resistance Point 0.4888
Last Price 0.4732
1st Support Level 0.4541
2nd Support Level 0.4351
3rd Support Level 0.4194

See More

52-Week High 2.8900
Fibonacci 61.8% 1.9235
Fibonacci 50% 1.6250
Fibonacci 38.2% 1.3265
Last Price 0.4732
52-Week Low 0.3600

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective